Application Nr Approved Date Route Status External Links
NDA009053 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Mercaptopurine Tablets Is Indicated For Treatment Of Adult And Pediatric Patients With Acute Lymphoblastic Leukemia (All) As Part Of A Combination Chemotherapy Maintenance Regimen. Mercaptopurine Tablets Is A Nucleoside Metabolic Inhibitor Indicated For Treatment Of Adult And Pediatric Patients With Acute Lymphoblastic Leukemia (All) As Part Of A Combination Chemotherapy Maintenance Regimen. (1.1) 1.1 Acute Lymphoblastic Leukemia Mercaptopurine Tablets Is Indicated For Treatment Of Adult And Pediatric Patients With Acute Lymphoblastic Leukemia (All) As Part Of A Combination Chemotherapy Maintenance Regimen.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Mercaptopurine MERCAPTOPURINE ZINC4658290

Comments